Xenograft assays showed that GABABR1 knockdown dramatically increased tumor growth compared with the control group (Figure 6A), while YAP1-TEAD inhibition with Peptide 17 reversed tumor volume (Figure 6B) and weight (Figure 6C) regardless of the GABABR1 knockdown. Here, YAP1 is linked to neoplasm.